143 related articles for article (PubMed ID: 30140014)
1. Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine.
Rechkoblit O; Choudhury JR; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2018 Aug; 8(1):12702. PubMed ID: 30140014
[TBL] [Abstract][Full Text] [Related]
2. Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine.
Yoon JH; Roy Choudhury J; Prakash L; Prakash S
J Biol Chem; 2019 Dec; 294(50):19048-19054. PubMed ID: 31685662
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η.
Rechkoblit O; Johnson RE; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2019 Nov; 9(1):16400. PubMed ID: 31704958
[TBL] [Abstract][Full Text] [Related]
4. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
5. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
6. Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.
Garcia-Diaz M; Murray MS; Kunkel TA; Chou KM
J Biol Chem; 2010 May; 285(22):16874-9. PubMed ID: 20348107
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for topoisomerase I inhibition by nucleoside analogs.
Gmeiner WH; Yu S; Pon RT; Pourquier P; Pommier Y
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):653-8. PubMed ID: 14565246
[TBL] [Abstract][Full Text] [Related]
8. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
10. Transformation kinetics of the 5'-chloro-5'-deoxy analogue of arabinosylcytosine.
Stankovicová M; Novotný L; Bachratá M; Bílková J; Rauko P
Neoplasma; 1999; 46(3):161-5. PubMed ID: 10613591
[TBL] [Abstract][Full Text] [Related]
11. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
Someya H; Waud WR; Parker WB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution.
Zhang H; Gao YG; van der Marel GA; van Boom JH; Wang AH
J Biol Chem; 1993 May; 268(14):10095-101. PubMed ID: 8486678
[TBL] [Abstract][Full Text] [Related]
13. DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC).
Chen YW; Chou KM
Int J Biochem Mol Biol; 2011; 2(4):340-6. PubMed ID: 22187668
[TBL] [Abstract][Full Text] [Related]
14. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted activities of DNA polymerase η: beyond translesion DNA synthesis.
Acharya N; Manohar K; Peroumal D; Khandagale P; Patel SK; Sahu SR; Kumari P
Curr Genet; 2019 Jun; 65(3):649-656. PubMed ID: 30535880
[TBL] [Abstract][Full Text] [Related]
16. Molecular structure of a DNA decamber containing an anticancer nucleoside arabinosylcytosine: conformational perturbation by arabinosylcytosine in B-DNA.
Gao YG; van der Marel GA; van Boom JH; Wang AH
Biochemistry; 1991 Oct; 30(41):9922-31. PubMed ID: 1911784
[TBL] [Abstract][Full Text] [Related]
17. Qualitative differences between replicative and repair synthesis of DNA in normal and transformed mouse cells as measured by precursor discrimination.
Elliott GC; Downes CS
Mutat Res; 1986 Nov; 166(3):295-302. PubMed ID: 3097531
[TBL] [Abstract][Full Text] [Related]
18. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
[TBL] [Abstract][Full Text] [Related]
19. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
[TBL] [Abstract][Full Text] [Related]
20. The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity.
Braess J; Voss S; Jahns-Streubel G; Schoch C; Haferlach T; Kern W; Keye S; Schleyer E; Hiddemann W
Br J Haematol; 2000 Jul; 110(1):170-9. PubMed ID: 10930995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]